CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients

Advances in Experimental Medicine and Biology

Volumn 457, Issue , 1999, Pages 251-258

  Baryshnikov, A Yu ^a   Polosukhina, E R ^a   Tupitsin, N N ^a   Gavrikova, N V ^a   Andreeva, L Yu ^a   Zabotina, T N ^a   Mayakova, S A ^a   Kurmashov, V I ^a   Syrkin, A B ^a   Kadagidze, Z G ^a   Blochin, D Yu ^a   Shishkin, Yu V ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Acute lymphoblastic leukemia; Apoptosis; CD95 (Fas APO 1) antigen; IPO 4

Indexed keywords

ANTINEOPLASTIC AGENT; FAS ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE METALLOENDOPEPTIDASE; MONOCLONAL ANTIBODY; TUMOR MARKER;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; APOPTOSIS; ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CHILD; CLINICAL TRIAL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOPHENOTYPING; INFANT; MALE; METHODOLOGY; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD95; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BLAST CRISIS; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEPRILYSIN; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032605792     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4811-9_27     Document Type: Article

References (8)

1. Baryshnikov A.Yu., Kadagidze Z.G., Tupitsin N.N., Machonova L.A.. Immunological phcnotypc of leukemic cell. Moscow, 1989,240.
2. Kotani-T; Aratake-Y; Kondo-S; Tamura-K; Ohtaki-S. Expression of functional Fas antigen on adult T-cell leukemia. Leuk-Res., 1994, 18(4), 305-310
3. Lucking-Famira KM; Daniel-PT; Moller-P; Krammer-PH; Debatin-KM APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice. Leukemia, 1994, 8(11), 1825-1833
4. Debatin K.-M., Goldman C.K., Waldman T.A., Krammer P.H. APO-l-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood, 1993, 81, 2972 - 2977
5. Debatin K.-M., Goldman C.K., Bamford R. et al. Monoclonal antibody mediated apoptosis in adult T cell leukemia, Lancet, 1990,335,447
6. Friesen-C; Herr-I; Krammer-PH; Debatin-KM .Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat-Med.,1996, 2(5), 574-577
7. Brunner T., Mogil R.J., LaFase D.,Yoo N.J., Mahboubl A. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature, 1995, 373, 441-444
8. Ju Shyr-Te, Panka D.J., Cui H., Ettinger R., Marshak-Rothstei. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature, 1995, 373, 444-448